Spica Therapeutics Appoints Jeff Abbey as Chief Executive Officer
PRIVATEOct 28, 2026
New to company · from RNatives“Abbey most recently served as CEO of RNatives, an RNA-based gene-regulating therapeutics company, where he has transitioned to Chairman of the Board.”
Position
Chief Executive Officer
Company
Spica Therapeutics
Jeff Abbey
BiotechnologyHealth CareTherapeutics
Description
Spica Therapeutics has named Jeff Abbey as its new Chief Executive Officer, bringing extensive experience in executive management and strategic execution. His leadership is expected to drive the company’s corporate strategy and expansion into new therapeutic areas.
Who to call at Spica Therapeutics, and when
A new leader at Spica Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Spica Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Spica Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Spica Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Spica Therapeutics
About
Spica Therapeutics is focused on developing innovative therapies for chronic diseases. The company leverages its proprietary platform to create precision treatments across various therapeutic areas. With a strong emphasis on building effective solutions, it aims to revolutionize patient care in the biopharmaceutical sector.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Spica Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
